In this context, antidepressant-induced bruxism could be due to an indirect inhibition of dopaminergic pathways due to an increase in extrapyramidal serotonin levels, which could explain why buspirone, a 5–HT1A receptor agonist has shown some efficacy in relieving bruxism [42]. The gene discussed is HTR1A; the disease is bruxism.